WKN DE: A2QHK9 / ISIN: US82835W1080

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Silverback Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
21:48:03	14,870	118
21:47:45	14,870	36
21:47:45	14,870	100
21:47:45	14,870	5
21:47:45	14,870	25
21:47:45	14,870	75
21:47:44	14,870	2
21:47:44	14,870	34
21:47:44	14,870	41
21:47:44	14,870	7
21:47:44	14,870	34
21:47:44	14,870	5
21:47:44	14,870	18
21:47:43	14,870	31
21:47:22	14,860	9
21:47:22	14,870	191
21:47:22	14,870	9
21:47:22	14,870	49
21:47:22	14,870	23
21:47:15	14,870	26
21:47:15	14,870	49
21:47:15	14,870	5
21:47:15	14,870	16
21:47:15	14,870	100
21:47:15	14,870	6
21:47:15	14,870	34
21:47:12	14,870	22
21:47:12	14,870	22
21:47:12	14,870	22
21:47:02	14,860	5
21:47:02	14,860	15
21:47:02	14,860	6
21:47:02	14,860	100
21:47:02	14,860	33
21:47:02	14,860	17

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Silverback Therapeutics Inc Registered Shs

Weitere Meldungen

21:59		Trump and Tucker Carlson Are Divided Over Israel-Iran Conflict
21:48		The dollar could be set up for a nice bounce soon, these charts show
21:27		Supreme Court Justices Disclose International Travel and Book Deals
21:16		Author J.L. Collins Talks About Achieving Financial Independence
21:05		Companies Ask Supreme Court to Fast-Track Challenge to Tariffs
21:04		OpenAI Signed a $200M Deal With the Defense Department: Why You Should Pay Attention
21:04		Jamie Dimon wants workers in the office. So why is he letting JPMorgan’s European chief work remotely?
20:59		Global X's New GXIG ETF Offers AI-Powered Bond ETF For Smarter Fixed Income Investing
20:57		Acurx Pharmaceuticals Shares Are Up Today: What's Going On?
20:57		Why Reddit Stock Is Jumping Today
20:56		SolarEdge Misses Out On Rebound, Loses Key Tax Credit Advantage: Analyst
20:45		If You'd Invested $5,000 in Kohl's Stock 3 Years Ago, Here's How Much You'd Have Today
20:36		Amazon CEO Says Generative AI Will Reduce Total Corporate Workforce
20:35		FrontView REIT A 'Special Situation' With Increased Takeover Potential Post-CFO Ousting: Analyst
20:29		RedWire Shares Are Down Today: What's Going On?
20:27		Why T-Mobile Stock Fell Today
20:22		These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News
20:18		Beyond Magnificent 7: Can Thematic ETFs Like IVES Lead The Next Wave Of AI Investing? CIO Cullen Rogers Explains
20:18		Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report
20:10		What's Going On With Digital Turbine Shares Today?
20:09		Vertiv Holdings Stock, 25% Off Highs, Is Now Riding Nvidia's AI Wave
20:01		Deep Dive Into Commerce Bancshares Stock: Analyst Perspectives (5 Ratings)
20:01		Arista Networks Options Trading: A Deep Dive into Market Sentiment
20:01		This Is What Whales Are Betting On Netflix
20:00		A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts
20:00		15 Analysts Assess Costco Wholesale: What You Need To Know
20:00		Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals
20:00		Stablecoins Pose 'Systemic Risk' To US Banks And Dollar, Former BoE Advisor Warns: 'They're Very Bad Customers For The Banking System'
20:00		Breaking Down Digital Realty Trust: 9 Analysts Share Their Views
20:00		What's Driving the Market Sentiment Around Texas Roadhouse?
20:00		Xbox Is Bringing These Call of Duty and Warcraft Games to Game Pass in June
20:00		P/E Ratio Insights for TTM Technologies
20:00		How Do Investors Really Feel About Boyd Gaming?
20:00		Breaking Down Advance Auto Parts: 11 Analysts Share Their Views
19:58		How to create a traditional pension — right now
19:57		Sunrun Receives Downgrade As Analyst Warns Business Model Relies On Inflated System Values For Tax Credits
19:52		Safety checks found ‘no major concerns’ on Air India 787 fleet, says watchdog
19:46		EXCLUSIVE: Apple's Growth Engine Appears Stalled - Is It Time To Swap iPhones For Dividends?
19:44		FuelCell Energy (FCEL) Stock Plummets 9% Amidst Renewable Energy Policy Fears: What's Going On?
19:41		Appian appoints former Newmont EVP, COO Atkinson as senior partner
19:40		Brussels proposes revamp of controversial securitisation rules
19:40		Brussels proposes revamp of controversial securitisation rules
19:39		T-Mobile Stock (TMUS) Plunges After SoftBank's $4.8B Share Sale: Report
19:38		Netflix is setting its sights on the theme-park world, after already taking over TV
19:36		NIO Shifts Gears In Europe, Adopts Distributor Sales For Wider Reach
19:30		Elon Musk's AI Bot Says Tesla's Golden Period Is Over—Sees 15-25% Risk Of 'Death Spiral'
19:30		How to watch River Plate vs. Urawa Reds From Anywhere For Free: Stream FIFA Club World Cup Soccer
19:29		Russian court approves state seizure of Moscow’s second-largest airport
19:26		Rainbow Rare Earth, Mosaic begin economic assessment on REE extraction in Brazil
19:26		Rolls-Royce calls for government to back plans for new engine

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Aker BioMarine AS Registered Shs 17 Education & Technology Group incorporation Unsponsored American Depositary Receipt Repr 2.5 Shs Conduit Holdings Allegro.eu Unsponsored American Depositary Receipt Repr 1-2Sh DoorDash

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	17.06.2025 22:03
Kaufwert:	EUR
	Hinzufügen Speichern

Silverback Therapeutics Aktie

WKN DE: A2QHK9 / ISIN: US82835W1080

Silverback Therapeutics Times and Sales (NAS)

Analysen zu Silverback Therapeutics Inc Registered Shs

Weitere Meldungen